Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations in infancy

Clinical and Vaccine Immunology

Volumn 14, Issue 10, 2007, Pages 1328-1333

  Southern, Jo ^a   McVernon, Jodie ^a,b   Gelb, David ^a   Andrews, Nick ^a   Morris, Rhonwen ^a   Crowley Luke, Annette ^a   Goldblatt, David ^c   Miller, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PERTUSSIS VACCINE;

ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; CHILD; CONTROLLED STUDY; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PROGRAM; HUMAN; IMMUNOGENICITY; INCIDENCE; INFANT; INFECTION PREVENTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT; VACCINE FAILURE;

ANTIBODIES, BACTERIAL; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GREAT BRITAIN; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MENINGITIS, HAEMOPHILUS; PERTUSSIS VACCINE; VACCINES, ACELLULAR; VACCINES, ATTENUATED; VACCINES, CONJUGATE;

EID: 35548957365     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00191-07     Document Type: Article

References (24)

1. Anderson, P., D. L. Ingram, M. E. Pichichero, and G. Peter. 2000. A high degree of natural immunologic priming to the capsular polysaccharide may not prevent Haemophilus influenzae type b meningitis. Pediatr. Infect. Dis. J. 19:589-591.
2. Barbour, M. L., R. T. Mayon-White, C. Coles, D. W. Crook, and E. R. Moxon. 1995. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J. Infect. Dis. 171:93-98.
3. Bernasconi, N. L., E. Traggiai, and A. Lanzavecchia. 2002. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298:2199-2202.
4. Booy, R., S. Hodgson, L. Carpenter, R. Mayon-White, M. Slack, J. Macfarlane, E. A. Haworth, M. Kiddle, S. Shribman, and J. S. Roberts. 1994. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet 344:362-366.
5. Eskola, J., J. Ward, R. Dagan, D. Goldblatt, F. Zepp, and C. A. Siegrist. 1999. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 354: 2063-2068.
6. Goldblatt, D., E. Miller, N. McCloskey, and K. Cartwright. 1998. Immunological response to conjugate vaccines in infants: follow up study. BMJ 16:1570-1571.
7. Goldblatt, D., P. Richmond, E. Millard, C. Thornton, and E. Miller. 1999. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. J. Infect. Dis. 180:538-541.
8. Goldblatt, D., M. Hussein, N. Andrews, L. Ashton, C. Virta, A. Melegaro, R. Pebody, R. George, A. Soininen, J. Edmunds, N. Gay, H. Kayhty, and E. Miller. 2005. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J. Infect. Dis. 192:387-393.
9. Heininger, U., R. Sanger, J. M. Jacquet, L. Schuerman, et al. 2007. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine, and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses. Vaccine 25:1055-1063.
10. Ho, F., J. E. Lortan, I. C. MacLennan, and M. Khan. 1986. Distinct short-lived and long-lived antibody-producing cell populations. Eur. J. Immunol. 16:1297-1301.
11. Johnson, N. G., J. U. Ruggeberg, G. F. Balfour, Y. C. Ue, H. Liddy, D. Irving, J. Sheldon, M. P. Slack, A. J. Pollard, and P. T. Heath. 2006. Haemophilus influenzae type b reemergence after combination immunization. Emerg. Infect. Dis. 12:937-941.
12. Käyhty, H., H. Peltola, V., Karanko, and P. H. Makela. 1983. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J. Infect. Dis. 147:1100.
13. Kitchin, N. R., J. Southern, R. Morris, F. Hemme, S. Thomas, M. W. Watson, K. Cartwright, and E. Miller. 2007. Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age. Arch. Dis. Child. 92:11-16.
14. McVernon, J., N. Andrews, M. P. Slack, and M. E. Ramsay. 2003. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet 361:1521-1523.
15. McVernon, J., A. J. Howard, M. P., Slack, and M. E. Ramsay. 2004. Long-term impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom. Epidemiol. Infect. 132:765-767.
16. McVernon, J., C. L. Trotter, M. P. Slack, and M. E. Ramsay. 2004. Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. BMJ 329:655-658.
17. Phipps, D. C., J. West, R. Eby, M. Koster, D. V. Madore, and S. A. Quataert. 1990. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J. Immunol. Methods 135:121-128.
18. Ramsay, M. E., E. Miller, N. Andrews, M. Slack, and P. Heath. 2004. Epidemiological data are essential. BMJ http://bmj.bmjjournals.com/cgi /eletters/bmj.38301.657014.79v1#893.
19. Ramsay, M. E., J. McVernon, N. J. Andrews, P. T. Heath, and M. P. Slack. 2003. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J. Infect. Dis. 88:481-485.
20. Salisbury, D. M., and N. T. Begg (ed.). 1986. Immunisation against infectious disease - the green book. HMSO Publications, London, United Kingdom.
21. Slifka, M. K., R. Antia, J. K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8:363-372.
22. Trotter, C. L., N. J. Andrews, E. B. Kaczmarski, E. Miller, and M. E. Ramsay. 2004. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364:365-367.
23. Urwin, G., M. F. Yuan, and R. A. Feldman. 1994. Prospective study of bacterial meningitis in North East Thames region, 1991-3, during introduction of Haemophilus influenzae vaccine. BMJ 309:1412-1414.
24. Vidor, E., A. Hofenbach, and M. A. Fletcher. 2001. Haemophilus influenzae type b vaccine: reconstitution of lyophilised PRP-T vaccine with a pertussis-containing paediatric combination vaccine, or a change in the primary series immunisation schedule, may modify the serum anti-PRP antibody responses. Curr. Med. Res. Opin. 17:197-209.